Quantitative evaluation of neuropharmacological trials.
D000203:Activities of Daily Living; D000367:Age Factors; D000547:Amantadine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D005221:Fatigue / Q000175:diagnosis; D006801:Humans; D007859:Learning Disabilities / Q000175:diagnosis; D009048:Motor Skills; D009103:Multiple Sclerosis / Q000175:diagnosis; D009422:Nervous System Diseases / Q000503:physiopathology*; D009460:Neurologic Examination; D009461:Neurologic Manifestations; D010300:Parkinson Disease / Q000503:physiopathology; D013997:Time Factors; D014202:Tremor / Q000175:diagnosis
D004295:Dihydroxyphenylalanine; D000547:Amantadine